Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Other Equity Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Other Equity
-$4.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
AstraZeneca PLC
LSE:AZN
Other Equity
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Other Equity
-$37m
CAGR 3-Years
-50%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Other Equity
-$360m
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Other Equity
-ÂŁ12.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Verona Pharma PLC's Other Equity?
Other Equity
-4.6m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Other Equity amounts to -4.6m USD.

What is Verona Pharma PLC's Other Equity growth rate?
Other Equity CAGR 3Y
0%

Over the last year, the Other Equity growth was 0%.

Back to Top